AB Sciex and University of Geneva collaborate

20-Sep-2010

The collaboration is focused on developing applications for use with a mass spectrometry system that combines qualitative and quantitative analysis at high resolution and high sensitivity with accurate mass.

AB Sciex is working with the University of Geneva\'s Mass Spectrometry Centre to create new workflows and analytical strategies to improve drug discovery and development. The collaboration is focused on developing applications for use with a mass spectrometry system that combines qualitative and quantitative analysis at high resolution and high sensitivity with accurate mass. AB Sciex will launch the system later this year.

Currently marketed accurate-mass systems are limited to producing qualitative results, according to AB Sciex, a life science analytical technology specialist headqurtered in California, US. These systems cannot match the sensitivity and high speed required for quantitative analysis.

The University of Geneva\'s Mass Spectrometry Centre is applying AB Sciex\'s technology for metabolite identification. The scientists at the centre will assist AB Sciex in developing workflows and software that will accelerate the adoption of the new platform within the pharmaceutical industry.

"The ability to integrate qualitative and quantitative analysis within a single platform enables new and better ways to think about conducting experiments," said Gerard Hopfgartner, professor and scientist at the University of Geneva\'s Mass Spectrometry Centre.

"By developing novel workflows to take advantage of the new platform, we will be able to better understand biological systems and improve the drug discovery process."

Companies